Posts in: investor

$6M fundraise closed
press releaseinvestor
eXoZymes Inc. Announces Closing of $6 Million Public OfferingJune 17, 2026
EXOZ announces pricing of public offering
press releaseinvestor
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and WarrantsJune 8, 2026
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compounds
investormedicinepress clippingscannabinoids
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compoundsMay 15, 2026
EXOZ investor presentation by Chris Marlett
investorvideo
Updated EXOZ investor presentation by Chris MarlettMay 11, 2026
Perriman at Nasdaq
investornutraceuticalsmedicinepress clippingsvideoperrimanNCT
Nasdaq: Damien Perriman interview on NCTApril 2, 2026
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
investornutraceuticalsmedicinevideoNCTcannabinoids
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026April 1, 2026
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
press releaseinvestor
eXoZymes Provides Fourth Quarter and Full Year 2025 UpdateMarch 31, 2026
Q4 + 2025 investor call
investor
Sign up: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026March 25, 2026
eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output
investornutraceuticalsmedicineperrimanNCT
EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade outputMarch 18, 2026
The Big Skinny: Lou Basenese states that eXoZymes is the BASF of 2026
investorpress clippingsvideo
The Big Skinny: Lou Basenese states that eXoZymes is the BASF of 2026February 16, 2026
Previous page
Page 1 of 9
Next page